Great @crfheart#TCT2022 slide by @rwyeh re: 🔑 operator attributes for safe-effective “high-risk” and “complex” (not the same BTW) PCI: I’ve personally become both more “aggressive” yet also more “thoughtful” over time and act with more “confidence” yet also more “humility”👍GC
I’ve observed that many (if not all) live operators at #TCT2022 operate their own table for procedures. I trained this way and got away from it recently. Curious to know everyone’s practice.
Do you pan for yourself in the cath lab? @fischman_david@DocSavageTJU@mmamas1973
Premiering at #TCT2022 is the new workflow for the how and what to assess #CMD. Created by a global group of experts. Thank you @nadia_sutton for presenting it today. And to @ziadalinyc amd @JEscaned for discussing it in the symposium this morning.
RESCUE: In pts w/ intermediate-risk acute PE, pharmaco-mechanical catheter-directed thrombolysis with the Bashir Endovascular Catheter reduced RV/LV ratio by 33.3% and PA obstruction index by 35.9% at 48 hrs #TCT2022
CLASP II D RCT: In symptomatic degenerative mitral regurgitation, PASCAL valve repair system safe and non-inferior to MitraClip, resulted in low composite MACE thru 30 days and sustained improved MR thru 6 mo #TCT2022
HALT: In pts with self-expanding TAVs, no relationship btw duration of implant and thrombus / inflammation scores. Neointimal thickening, structural change, and calcification scores increased with time. #TCT2022